These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26714373)

  • 1. A NOVEL FLT4 GENE MUTATION AND MR LYMPHANGIOGRAPHY IN A CHINESE FAMILY WITH MILROY DISEASE.
    Liu NF; Yu Z; Luo Y; Sun D; Yan Z
    Lymphology; 2015 Jun; 48(2):93-6. PubMed ID: 26714373
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Liu N; Gao M
    Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34681005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel FLT4 mutation identified in a patient with Milroy disease.
    DiGiovanni RM; Erickson RP; Ohlson EC; Bernas M; Witte MH
    Lymphology; 2014 Mar; 47(1):44-7. PubMed ID: 25109169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rare Variants in LAMA5 Gene associated with FLT4 and FOXC2 Mutations in Primary Lymphedema May Contribute to Severity.
    Liu NF; Yu ZY; Sun D; Lou Y
    Lymphology; 2016 Dec; 49(4):192-204. PubMed ID: 29908552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical variability in a Japanese hereditary lymphedema type I family with an FLT4 mutation.
    Mizuno S; Yamada Y; Yamada K; Nomura N; Wakamatsu N
    Congenit Anom (Kyoto); 2005 Jun; 45(2):59-61. PubMed ID: 15904433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation in vascular endothelial growth factor-C, a ligand for vascular endothelial growth factor receptor-3, is associated with autosomal dominant milroy-like primary lymphedema.
    Gordon K; Schulte D; Brice G; Simpson MA; Roukens MG; van Impel A; Connell F; Kalidas K; Jeffery S; Mortimer PS; Mansour S; Schulte-Merker S; Ostergaard P
    Circ Res; 2013 Mar; 112(6):956-60. PubMed ID: 23410910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the coding regions of VEGFR3 and VEGFC in Milroy disease and other primary lymphoedemas.
    Connell FC; Ostergaard P; Carver C; Brice G; Williams N; Mansour S; Mortimer PS; Jeffery S;
    Hum Genet; 2009 Jan; 124(6):625-31. PubMed ID: 19002718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Milroy case with FLT4/VEGFR3 mutation and an unusual skin biopsy.
    Liu NF; Yu ZY; Lou Y; Sun D
    Br J Dermatol; 2019 Jan; 180(1):223-224. PubMed ID: 30169892
    [No Abstract]   [Full Text] [Related]  

  • 9. A novel VEGFR3 mutation causes Milroy disease.
    Butler MG; Dagenais SL; Rockson SG; Glover TW
    Am J Med Genet A; 2007 Jun; 143A(11):1212-7. PubMed ID: 17458866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel VEGFR-3 missense mutation in a Chinese family with hereditary lymphedema type I.
    Yu Z; Wang J; Peng S; Dong B; Li Y
    J Genet Genomics; 2007 Oct; 34(10):861-7. PubMed ID: 17945164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of FLT4 mutations associated with Nonne-Milroy lymphedema.
    Verstraeten VL; Holnthoner W; van Steensel MA; Veraart JC; Bladergroen RS; Heckman CA; Keskitalo S; Frank J; Alitalo K; van Geel M; Steijlen PM
    J Invest Dermatol; 2009 Feb; 129(2):509-12. PubMed ID: 18719607
    [No Abstract]   [Full Text] [Related]  

  • 12. Milroy's primary congenital lymphedema in a male infant and review of the literature.
    Kitsiou-Tzeli S; Vrettou C; Leze E; Makrythanasis P; Kanavakis E; Willems P
    In Vivo; 2010; 24(3):309-14. PubMed ID: 20555004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compound heterozygosity for a variably penetrant variant and a variant of unknown significance in FLT4 causes fully penetrant Milroy's lymphedema.
    Kim J; Lim SY
    Lymphology; 2022; 55(2):41-46. PubMed ID: 36170577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FLT4/VEGFR3 and Milroy disease: novel mutations, a review of published variants and database update.
    Gordon K; Spiden SL; Connell FC; Brice G; Cottrell S; Short J; Taylor R; Jeffery S; Mortimer PS; Mansour S; Ostergaard P
    Hum Mutat; 2013 Jan; 34(1):23-31. PubMed ID: 23074044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FLT4 causes developmental disorders of the cardiovascular and lymphovascular systems via pleiotropic molecular mechanisms.
    Monaghan RM; Naylor RW; Flatman D; Kasher PR; Williams SG; Keavney BD
    Cardiovasc Res; 2024 Sep; 120(10):1164-1176. PubMed ID: 38713105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and genetic study of 46 Italian patients with primary lymphedema.
    Michelini S; Degiorgio D; Cestari M; Corda D; Ricci M; Cardone M; Mander A; Famoso L; Contini E; Serrani R; Pinelli L; Cecchin S; Bertelli M
    Lymphology; 2012 Mar; 45(1):3-12. PubMed ID: 22768468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Missense Mutation in FLT4 Causes Autosomal Recessive Hereditary Lymphedema.
    Melikhan-Revzin S; Kurolap A; Dagan E; Mory A; Gershoni-Baruch R
    Lymphat Res Biol; 2015 Jun; 13(2):107-11. PubMed ID: 26091405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wide clinical spectrum in a family with hereditary lymphedema type I due to a novel missense mutation in VEGFR3.
    Spiegel R; Ghalamkarpour A; Daniel-Spiegel E; Vikkula M; A Shalev S
    J Hum Genet; 2006; 51(10):846-850. PubMed ID: 16924388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A family with Milroy disease caused by the FLT4/VEGFR3 gene variant c.2774 T > A.
    Sui Y; Lu Y; Lin M; Ni X; Chen X; Li H; Jiang M
    BMC Med Genomics; 2021 Jun; 14(1):151. PubMed ID: 34103024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary lymphedema type I associated with VEGFR3 mutation: the first de novo case and atypical presentations.
    Ghalamkarpour A; Morlot S; Raas-Rothschild A; Utkus A; Mulliken JB; Boon LM; Vikkula M
    Clin Genet; 2006 Oct; 70(4):330-5. PubMed ID: 16965327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.